Cardio Research s.r.o.
- Address
- lock Available on a paid plan
Cardio Research s.r.o. - Cardiovascular Clinical Research Center
Cardio Research s.r.o. is a specialized clinical research facility dedicated to advancing cardiovascular medicine through participation in pivotal Phase III clinical trials. The center focuses on investigating novel therapeutic approaches for patients with complex cardiovascular conditions, including heart failure, atherosclerotic disease, and cardiometabolic disorders.
- Heart failure management with combination therapies targeting cardiac and renal function
- Lipid-lowering interventions for cardiovascular disease prevention, including lipoprotein(a) and LDL-cholesterol reduction
- Cardiometabolic research examining cardiovascular and kidney outcomes in obesity
The research center demonstrates particular expertise in evaluating major adverse cardiovascular events (MACE) outcomes, including cardiovascular death, myocardial infarction, and stroke. Their trial portfolio includes studies of innovative drug combinations such as vicadrostat with empagliflozin and balcinrenone with dapagliflozin for heart failure, as well as advanced RNA-based therapies like inclisiran and pelacarsen for lipid management. The center's comprehensive approach addresses the interconnected nature of cardiovascular disease, heart failure, and kidney function, positioning them at the forefront of integrated cardiorenal research.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1AstraZeneca AB2active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG5trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Cardio Research s.r.o.
lock Showing 1 of 14 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation | Janssen Cilag International | Phase III | Not Recruiting | Aug 2023 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Inclisiran | 3 | Unknown | 2021-11-26 | 2023-09-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.